Development of a transition program for pediatric patients with renal disease

Sahar Siddiqui1, Cortney Taylor Zimmerman2, Brittany Garza1

  • 1Baylor College of Medicine/Texas Children's Hospital, Department of Pediatrics, Division of Nephrology, 1102 Bates Ave., Ste. 245, Houston, TX 77030, USA.

Health Care Transitions
|December 23, 2024
PubMed

Insights

A new structured health care transition (HCT) program improved care for pediatric kidney disease patients moving to adult services. The two-step clinic and dedicated team enhanced patient self-management skills and provider satisfaction.

Area of Science:

  • Nephrology
  • Pediatric Healthcare
  • Health Services Research

Background:

  • The transition from pediatric to adult healthcare presents significant challenges for patients with renal disease.
  • Inadequate transition processes can exacerbate disease-related morbidity in young adults.
  • A structured approach is needed to ensure continuity of care for these vulnerable patients.

Purpose of the Study:

  • To develop and implement a structured health care transition (HCT) program for pediatric patients with kidney disease.
  • To address the identified barrier of a non-standardized HCT process.
  • To improve patient outcomes and satisfaction during the transition to adult care.

Main Methods:

  • Utilized quality improvement methodology to establish an interdisciplinary transition team.
  • Conducted a needs assessment to identify barriers to effective HCT.
  • Implemented a joint, two-step transition clinic (pediatric and adult) with a standardized policy and feedback mechanisms.

Main Results:

  • 27 patients completed the first step and 22 completed the second step of the transition clinic.
  • The majority of patients (41%) had kidney transplants, with a median transition age of 20 years.
  • 100% of patients received the transition policy and reported improved self-management skills; 100% of nephrologists were satisfied with the program.

Conclusions:

  • A structured HCT program, developed with a dedicated team, was successfully established and well-received.
  • This program represents a crucial advancement in standardizing care for pediatric kidney disease patients transitioning to adult healthcare.
  • The findings highlight the program's effectiveness in enhancing patient preparedness and provider satisfaction.
Abstract

Related Concept Videos

Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
63
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
121
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
261
Renal Drug Excretion: Tubular Reabsorption01:25

Renal Drug Excretion: Tubular Reabsorption

Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
92
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
53
Renal Drug Excretion: Overview01:15

Renal Drug Excretion: Overview

As primary excretory organs, the kidneys maintain homeostasis by removing waste substances from the bloodstream. They comprise over a million units called nephrons, which serve as the kidney's functional units.
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
111